Skip to content

Mark Elliott Boulding, Exec. VP and CLO at Ptc Therapeutics, sold PTCT on Jul 6, 2026

Data as of Oct 16

▼ SELL$64.4K745 shares at $86.38Mark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.
Watch PTCT
Traded
Jul 6, 2026
Disclosed
Jul 8, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Mark Elliott Boulding, Exec. VP and CLO at Ptc Therapeutics, sold PTCT on Jul 6, 2026TRADEDDISCLOSED
PTCTSimilar stocks (XLV — its sector index fund), rebased to PTCT's price on the disclosure day
PTCT since disclosure
−33.1%
after the sale
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund

Change in closing price from Jul 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$70.3Kdisclosed Jul 8 · filed 2 days after the trade
  2. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$55.4Kdisclosed Jul 8 · filed 2 days after the trade
  3. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$32.2Kdisclosed Jul 8 · filed 2 days after the trade
  4. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$87.4Kdisclosed Jul 8 · filed 2 days after the trade
  5. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$51.9Kdisclosed Jul 8 · filed 2 days after the trade
  6. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$26Kdisclosed Jul 8 · filed 2 days after the trade
  7. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$44.6Kdisclosed Jul 8 · filed 2 days after the trade

See every trade on PTCT →